• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY WALLFLEX¿ ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY WALLFLEX¿ ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00516920
Device Problems Partial Blockage (1065); Material Deformation (2976)
Patient Problems Vomiting (2144); Ulcer (2274)
Event Date 10/22/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient's exact age is unknown; however it was reported that the patient was over the age of 18.(b)(4) stent blocked/occluded.(b)(4) stent damaged.According to the complainant, the suspect device has been disposed and is not available for return.If any further relevant information is received, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that a wallflex partially covered esophageal stent was implanted to treat a stricture in the distal oesophagus during a procedure performed on (b)(6) 2013.According to the complainant, the patient had been lost to follow up post initial stent placement procedure.The patient presented with hematemesis and was found to have a gastric ulcer on an unknown date in (b)(6) 2015.The hematemesis and gastric ulcer were treated during a laparoscopic procedure and oversew.The physician noted overgrowth at the top of the stent during a gastroscopy procedure and on (b)(6) 2015 a wallflex fully covered esophageal stent was implanted within the indwelling stent in order to create pressure necrosis.During a repeat gastroscopy procedure on (b)(6) 2015, the wallflex fully covered esophageal stent was removed from the patient without issue.However the physician noted that both the proximal and distal ends of the wallflex partially covered esophageal stent appeared to have broken down with sharp edges.The physician was unable to safely remove the wallflex partially covered esophageal stent endoscopically.The physician confirmed that the hematemesis and gastric ulcer had resolved.The wallflex partially covered esophageal stent was successfully removed on an unknown date using a combination of open surgery through the stomach and endoscopic techniques.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX¿ ESOPHAGEAL
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
nancy cutino
100 boston scientific way
marlborough, MA 01752
5086834000
MDR Report Key5221533
MDR Text Key31073044
Report Number3005099803-2015-03212
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K073266
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/22/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/26/2014
Device Model NumberM00516920
Device Lot Number15203983
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/22/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-